Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
11/03/2005 | WO2005103248A1 Mutated glucose dehydrogenase |
11/03/2005 | WO2005103230A2 Soy peptone as a nitrogen source in preparing meningococcal conjugates |
11/03/2005 | WO2005103229A2 Transgenomic mitochondria, transmitochondrial cells and organisms, and methods of making and using |
11/03/2005 | WO2005103228A2 L-amino acid-producing bacterium and a method for producing l-amino acid |
11/03/2005 | WO2005102508A1 Microbial encapsulation |
11/03/2005 | WO2005102031A1 Algae intensive-cultivation apparatus and cultivating method |
11/03/2005 | WO2005078113B1 Method for producing l-threonine using bacteria belonging to the genus escherichia |
11/03/2005 | WO2005050215A8 Selection of lactic acid bacteria enhancing the immune response against streptococcus pneumoniae |
11/03/2005 | WO2005021722A3 METHODS AND COMPOSITIONS FOR INHIBITION OF NUCLEAR FACTOR κB |
11/03/2005 | WO2005017159A3 Microbial production of l-ascorbic acid |
11/03/2005 | WO2005014790A3 Polypeptides having oxaloecetate hydrolase activity and polynucleotides encoding same |
11/03/2005 | WO2004081034A3 Altering metabolism in biological processes |
11/03/2005 | WO2004072243A3 Macrocyclic hepatitis c serine protease inhibitors |
11/03/2005 | WO2004060909A3 Increasing production of proteins in gram-positive microorganisms |
11/03/2005 | WO2003062173A8 Alanine 2,3- aminomutase |
11/03/2005 | WO2003000842A3 Novel proteins and nucleic acids encoding same |
11/03/2005 | US20050246789 Polypeptide having larvae growth inhibiting or insecticidal effect on scarabaeidae insects |
11/03/2005 | US20050246780 Phytases, nucleic acids encoding them and methods for making and using them |
11/03/2005 | US20050245722 Method for decomposing polyesters containing aromatic moieties, a denier reduction method of fiber, and microorganisms having activity of decomposing the polyester |
11/03/2005 | US20050245598 Antiproliferative activity and is most unlikely a substrate for P-glycoprotein and/or Multidrug Resistant Protein |
11/03/2005 | US20050245463 Novel antiretroviral sulfolipids extracted from spirulinae, method for obtaining same, compositions containing same and use thereof as inhibitors of the hiv virus reverse transcriptase |
11/03/2005 | US20050245454 Methods and compositions for impairing multiplication of HIV-1 |
11/03/2005 | US20050245443 Bacteria strain and bacteriocin produced therefrom |
11/03/2005 | US20050245398 Biological composition for enhancing vegetation growth |
11/03/2005 | US20050244947 production of a clear extra-chromosomal nucleic acid containing lysate from a cell solution by separating unwanted cellular components (e.g. cell debris, proteins, genomic DNA) in a gentle and non-disruptive manner by flotation |
11/03/2005 | US20050244946 Method of purifying oocysts using enzymatic digestion of fecal debris |
11/03/2005 | US20050244945 Light weight medium for growing microorganisms |
11/03/2005 | US20050244944 Light weight medium for growing microorganisms |
11/03/2005 | US20050244943 Cell concentration and pathogen recovery |
11/03/2005 | US20050244939 Variant aldolase and processes for producing an optically active IHOG and an optically active monatin using the same |
11/03/2005 | US20050244938 Manzamine-producing actinomycetes |
11/03/2005 | US20050244935 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
11/03/2005 | US20050244931 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
11/03/2005 | US20050244930 IL-21 antagonists |
11/03/2005 | US20050244928 Method of producing recombinant proteins |
11/03/2005 | US20050244927 Process for producing polypeptides |
11/03/2005 | US20050244926 Polypeptide which acts on fructosyl valyl histidine to produce alpha-ketoaldehyde, valyl histidine and hydrogen peroxide; stability; use as enzyme for diagnosis |
11/03/2005 | US20050244925 Proteases from gram-positive organisms |
11/03/2005 | US20050244924 Methods and constructs for high yield expression of clostripain |
11/03/2005 | US20050244923 from Stachybotrys parvispora with specific amino acid sequence; useful in modifying the color associated with dyes and colored compounds, as well as in anti-dye transfer during fabric washing; novel phenol oxidizing enzymes; for stain bleaching or anti dye transfer; amino acid and nucleic acid sequences |
11/03/2005 | US20050244922 Bacillus host cell |
11/03/2005 | US20050244921 Fluorescent protein variants and methods for making same |
11/03/2005 | US20050244919 Method of producing riboflavin |
11/03/2005 | US20050244888 Antibodies to human chemokine beta-9 |
11/03/2005 | US20050244878 BGL5 beta-glucosidase and nucleic acids encoding the same |
11/03/2005 | US20050244877 Splice variants of CD40-receptor |
11/03/2005 | US20050244859 Cell based assay |
11/03/2005 | US20050244857 Death domain containing receptor 4 |
11/03/2005 | US20050244840 Method of screening anti-mycobacterial molecules |
11/03/2005 | US20050244837 Method and device for sample preparation control |
11/03/2005 | US20050244817 Mammalian genes involved in viral infection and tumor suppression |
11/03/2005 | US20050244435 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis |
11/03/2005 | US20050244428 Site-directed mutagenesis; plasmid vectors; Dengue virus |
11/03/2005 | US20050244427 Isolation and production of bioactive marine products |
11/03/2005 | US20050244408 gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-IGF-IR antibodies; colorectal or breast cancer tumor |
11/03/2005 | US20050244398 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
11/03/2005 | US20050244392 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
11/03/2005 | US20050244374 Enveloped miroorganism |
11/03/2005 | US20050244372 Interleukin-3 (IL-3) multiple mutation polypeptides |
11/03/2005 | US20050244370 Selective local activation of members of the TNF receptor family by systemically inactive non-antibody TNF ligand fusion proteins |
11/03/2005 | CA2606322A1 Microbial encapsulation |
11/02/2005 | EP1591526A2 Frazzled nucleotide sequences, expression products, compositions and uses |
11/02/2005 | EP1591520A2 Microorganism producing L-threonine having inactivated tyR gene, method of producing the same and method of producing L-threonine using the microorganism |
11/02/2005 | EP1591267A2 Compositions, systems, and methods for imaging |
11/02/2005 | EP1590488A2 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
11/02/2005 | EP1590476A2 Protein fragment complementation assays for high-throughput and high-content screening |
11/02/2005 | EP1590463A2 Bacteria and process for producing chemical compounds by said bacteria |
11/02/2005 | EP1590444A2 Use of oxalate deficient aspergillus niger strains for producing a polypeptide |
11/02/2005 | EP1590443A2 Surface expression of biologically active proteins in bacteria |
11/02/2005 | EP1590442A2 Macrocyclic hepatitis c serine protease inhibitors |
11/02/2005 | EP1590440A2 Cell-killing molecules and methods of use thereof |
11/02/2005 | EP1590439A2 Nucleic acid antigens embedded in thermoplastic |
11/02/2005 | EP1590436A2 Rat receptor tyrosine kinase, kdr |
11/02/2005 | EP1590434A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
11/02/2005 | EP1590433A2 Diagnosis and prognosis of breast cancer patients |
11/02/2005 | EP1590047A1 Composition comprising lactobacilli or bifidobacteria and use thereof |
11/02/2005 | EP1357930B1 Histidine-rich glycoprotein (hrgp) for inhibiting angiogenesis |
11/02/2005 | EP1183355B1 T-bet compositions and methods of use thereof |
11/02/2005 | EP1141237B1 Pth receptor and screening assay utilizing the same |
11/02/2005 | EP1124835B1 Uses of sulfated fuco-oligosaccharides for plant protection |
11/02/2005 | EP1005488B1 Receptor that binds trail |
11/02/2005 | EP1002092B1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
11/02/2005 | EP0962525B1 Phage bonded to nuclear location signal |
11/02/2005 | EP0956357B1 Invertase inhibitor |
11/02/2005 | EP0951537B1 Recombinant collagen produced by plants, methods for obtaining them and uses |
11/02/2005 | CN1692124A P53 binding T cell receptor molecules and uses thereof |
11/02/2005 | CN1691964A Epitope sequences |
11/02/2005 | CN1690213A Method for the production of a fermentation product from an organism |
11/02/2005 | CN1690203A Beta-amyloid peptide-binding proteins and polynucleotides encoding the same |
11/02/2005 | CN1690192A Soluble IL-4 receptor prokaryotic gene engineering bacterium and antagon screening model with the receptor as target location |
11/02/2005 | CN1690191A L-amino acid-producing bacteria and process for producing L-amino acid |
11/02/2005 | CN1690190A Process for preparing immobilization compound microorganism preparation for controlling secondary pollution of river channel bed mud |
11/02/2005 | CN1690189A Bacillus for killing plant parasitic nematode and its preparation process and use thereof |
11/02/2005 | CN1690188A Method for preparing pyruvic acid and its special engineering bacterium |
11/02/2005 | CN1690187A Method for preparing hirsutella polysporaZK10 of parasitic nematode and use thereof |
11/02/2005 | CN1690186A Laccase, preparing method thereof and strain special for same |
11/02/2005 | CN1225555C Human TOLL-like receptor proteins, related reagents and methods |
11/02/2005 | CN1225552C Microorganism for producing riboflavin and method for producing riboflavin using the same |
11/02/2005 | CN1225551C Liquid-solid combined fermentation process of probiotics by using bifidobacteria as main component |
11/02/2005 | CN1225550C Host cell expressing reduced levels of metalloprotease and methods using host cell in protein production |